Low Tension Glaucoma - 25 Studies Found Recruiting : Efficacy and Safety of COMBIGAN® in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG) : Glaucoma, Open-Angle Normal Tension Glaucoma : 2016-05-02 : Drug: brimonidine tartrate/timolol malate Ophthalmic Solution Completed : Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma : Normal Tension Glaucoma Ocular Hypertension : 2013-11-21 : Drug: Travoprost Ophthalmic Solution 0.004% benzalkonium chloride (BAC) free Completed : IOP Lowering Effects of Topical Anesthetics Used Frequently in the Ophthalmology Clinic : Normal Tension Glaucoma : 2010-12-02 Completed : Validation of Retinal Oximetry in Glaucoma Patients: a Structural and Functional Correlation : Open Angle Glaucoma Low Tension Glaucoma : 2011-06-28 Completed : Effect of Alphagan on Retinal Blood Flow Autoregulation and Motion Detection in Patients With Normal Pressure Glaucoma : Glaucoma : 2010-04-14 : Drug: brimonidine 0.15% One drop in each eye three times a day for 8 weeks. Recruiting : Metabolomics in Surgical Ophthalmological Patients : Primary Open-angle Glaucoma Low Tension Glaucoma : 2017-03-26 : Diagnostic Test: Metabolomics analysis of patient samples Metabolomics analysis of patient samples by ma Recruiting : Psychopathology of Normal-tension Glaucoma in Hong Kong Chinese Out-patient : Glaucoma : 2006-05-08 Completed : Pilot Study on Ambulatory Intraocular Pressure and Blood Pressure Monitoring in Glaucoma : Normal-Tension Glaucoma : 2013-07-26 : Device: Sensimed Triggerfish I Withdrawn : The Antioxidant Effect of Routine Vascular Therapy for Normal Tension Glaucoma Patients : Primary Open Angle Glaucoma : 2007-04-24 Not yet recruiting : Additive Effect of Twice-daily Brinzolamide 1% / Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma : Glaucoma : 2017-05-09 : Drug: brinzolamide 1% / brimonidine 0.2% <<< Previous | Next >>>
